Congress trades in KalVista Pharmaceuticals (KALV)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in KalVista Pharmaceuticals (KALV) since 2022: 1 buy and 0 sales. The most recent was disclosed on Jan 20, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 1 / 0
- Reported value
- $1K–$15K
Who traded KALV
MemberBuysSalesLast disclosed
- Rep. Chris Jacobs (R-NY-27)1 buy · 0 sales10Jan 20, 2023
All trades
DisclosedTradeAmount
- Jan 20, 2023$1K–$15K
Rep. Chris Jacobs (R-NY-27)
Bought KalVista Pharmaceuticals KALV
$1K–$15K · Traded Dec 12, 2022 · disclosed Jan 20, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.